Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
162.6 USD | +0.92% | -0.10% | -10.01% |
May. 09 | Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up | MT |
May. 08 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday | MT |
Business Summary
Number of employees: 10,000
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 1,416 | 100.0 % | 2,459 | 100.0 % | +73.65% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
45.9
%
| 503 | 35.5 % | 1,128 | 45.9 % | +124.46% |
China
44.8
%
| 840 | 59.3 % | 1,102 | 44.8 % | +31.18% |
Europe
8.2
%
| - | - | 202 | 8.2 % | - |
Rest of World
1.1
%
| 73 | 5.2 % | 27 | 1.1 % | -63.70% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,244,457,968 | 1,222,239,074 ( 98.21 %) | 0 | 98.21 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
LEAP THERAPEUTICS, INC. 2.87% | 734,844 | 2.87% | 2,329,455 $ |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.66% | 16.85B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
+3.75% | 13.76B | |
+36.70% | 12.46B | |
+295.70% | 8.12B |
- Stock Market
- Equities
- BGNE Stock
- Company BeiGene, Ltd.